Trials / Unknown
UnknownNCT03392103
Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Zhongnan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether raltitrexed concurrent with IMRT is safe, tolerable and effective in the treatment for patients with local-advanced gastric cancer after D0/D1 radical resection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Raltitrexed | concurrent chemotherapy |
| RADIATION | postoperative radiotherapy | concurrent postoperative radiation therapy |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2018-01-05
- Last updated
- 2018-01-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03392103. Inclusion in this directory is not an endorsement.